| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 269,327 | 230,158 | 163,839 | 223,861 | | Cost of Revenue | 90,021 | 82,288 | 87,787 | 112,649 | | | Gross Profit | 179,306 | 147,870 | 76,052 | 111,212 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,314 | 10,282 | 8,980 | 41,905 | | Non Recurring |
-
|
-
|
-
| (43,068) | | Others | 101,273 | 100,315 | 100,034 | 97,893 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 66,719 | 37,273 | (32,962) | 14,482 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,069 | (163,816) | (22,161) | 7,064 | | Earnings Before Interest And Taxes | 77,788 | (126,543) | (55,123) | 21,546 | | Interest Expense | 15,647 | 18,693 | 14,680 | 16,318 | | Income Before Tax | 62,141 | (145,236) | (69,803) | 5,228 | | Income Tax Expense | 26,286 | (52,073) | (26,044) | 8,264 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 35,855 | (93,163) | (43,759) | (3,036) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 35,855 | (93,163) | (43,759) | (3,036) | | Preferred Stock And Other Adjustments | (4,911) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,944 | ($93,163) | ($43,759) | ($3,036) |
|
0.51% Nasdaq 0.00%
Income Statement
